INTELLIGENT BIO SOLUTIONS INC. Other Receivables, Net, Current
INTELLIGENT BIO SOLUTIONS INC. (INBS) had Other Receivables, Net, Current of $4.02 thousand as of 2026-06-30, per its 10-K filed 2026-08-19.
Financial Statements › Notes › Nontrade Receivables
us-gaap:OtherReceivablesNetCurrent · last filed 2026-08-19
- 2026-06-30: Other Receivables, Net, Current $4.02K.
- 2025-06-30: Other Receivables, Net, Current $87.16K; Other Receivables, Net, Current as first filed $20.00K.
- 2024-06-30: Other Receivables, Net, Current $6.30K.
- 2023-06-30: Other Receivables, Net, Current $20.13K.
| Period end | Other Receivables, Net, Current | Other Receivables, Net, Current as first filed |
|---|---|---|
| 2026-06-30 | $4.02K 10-K · filed 2026-08-19 | |
| 2025-06-30 | $87.16K 10-K · filed 2026-08-19 | $20.00K 10-K · filed 2025-08-15 |
| 2024-06-30 | $6.30K 10-K · filed 2025-08-15 | |
| 2023-06-30 | $20.13K 10-K · filed 2024-09-18 | |
| 2022-12-31 | $63.18K 10-Q · filed 2023-02-14 | |
| 2022-09-30 | $7.05K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $25.44K 10-K · filed 2023-08-23 | |
| 2022-03-31 | $118.78K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $28.16K 10-Q · filed 2022-02-11 | |
| 2021-09-30 | $8.80K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $1.60K 10-K · filed 2022-09-22 | |
| 2021-03-31 | $7.60K 10-Q · filed 2021-05-13 | |
| 2020-06-30 | $12.08K 10-K · filed 2021-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |